TipRanks
Advertisement
Advertisement
Percheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach
PremiumCompany AnnouncementsPercheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach
6d ago
Percheron Therapeutics Issues 300 Million New Shares to Institutional and Sophisticated Investors
Premium
Company Announcements
Percheron Therapeutics Issues 300 Million New Shares to Institutional and Sophisticated Investors
1M ago
Percheron Therapeutics to List 300 Million New Shares on ASX
Premium
Company Announcements
Percheron Therapeutics to List 300 Million New Shares on ASX
1M ago
Percheron Therapeutics Plans Major Share and Option Issue on ASX
PremiumCompany AnnouncementsPercheron Therapeutics Plans Major Share and Option Issue on ASX
1M ago
Percheron Therapeutics Details Equity Interests of New Director Deborah Ambrosini
Premium
Company Announcements
Percheron Therapeutics Details Equity Interests of New Director Deborah Ambrosini
1M ago
Percheron Therapeutics Cancels Unmet Options in Director Incentive Plan
Premium
Company Announcements
Percheron Therapeutics Cancels Unmet Options in Director Incentive Plan
1M ago
Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G
PremiumCompany AnnouncementsPercheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G
2M ago
Percheron Therapeutics Adds New Shares to ASX Quotation
Premium
Company Announcements
Percheron Therapeutics Adds New Shares to ASX Quotation
2M ago
Percheron Therapeutics names Michael Baker CEO as James Garner moves to non-executive role
Premium
Company Announcements
Percheron Therapeutics names Michael Baker CEO as James Garner moves to non-executive role
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―